[ad_1] TAIPEI, 31. Oktober 2025 /PRNewswire/ — Mycenax Biotech Inc. (TWO:4726), ein führendes CDMO-Unternehmen für Biologika mit Sitz in Taiwan, gab die Unterzeichnung einer Lizenzvereinbarung mit dem japanischen Unternehmen RIN Institute Inc. bekannt, die Mycenax […]
Tag: Biotechnology
Mycenax et RIN signent un accord de licence pour faire progresser le développement d’ADC à l’aide de la technologie de liaison exclusive de RIN
[ad_1] TAIPEI, 31 octobre 2025 /PRNewswire/ — Mycenax Biotech Inc. (TWO:4726), une CDMO de produits biologiques de premier plan basée à Taïwan, a annoncé la signature d’un accord de licence avec RIN Institute Inc. basé […]
Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
[ad_1] SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its participation in the Jefferies Global Healthcare Conference being held November 17-20, 2025 in London. Jefferies Global […]
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation
[ad_1] Presentation and Q&A session scheduled for post-market on Thursday, November 6, 2025 BOSTON, Oct. 30, 2025 /PRNewswire/ — Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”) today announced that it plans to host a presentation […]
Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities
[ad_1] This partnership enhances Piramal’s robust, existing payload-linker and bioconjugation capabilities. Through this agreement, Piramal can now offer clients a broader range of payload-linkers, and faster bioconjugate development times, thereby improving its service offerings and […]
